|
KR20130104924A
|
|
Antiviral composition including cord blood multipotent stem cell-derived protein and process for preparing the same
|
|
KR20120095580A
|
|
Renal protective composition including cord blood multipotent stem cell-derived protein and process for preparing the same
|
|
KR20120000834A
|
|
Protein composition derived from umbilical cord blood mesenchymal stem cell produced by using non-serum culture medium comprising soy hydrolisate
|
|
KR20110017233A
|
|
COMPOSITION CONTAINING POLY-γ-GLUTAMIC ACID FOR PROTECTING CELL IN CELL CULTURE
|
|
KR20100038521A
|
|
Process of fractionating umbilical cord blood wastes and cell culture media composition comprising the fraction obtained therefrom
|
|
KR20090127978A
|
|
Stem cell transplantation method and composition for cell therapy with endovascular interventional techniques using basilar artery
|
|
KR20090127980A
|
|
Percutaneous intrathecal transplantation of stem cells on spinal cord injured animals
|
|
KR20090090850A
|
|
Culture medium composition for in vitro proliferation of mesenchymal stem cell derived from umbilical cord blood comprising soy hydrolisate
|
|
KR20090065720A
|
|
Composition for cell therapy of liver cirrhosis with stem cell derived from human umbilical cord blood
|
|
KR20050045326A
|
|
Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood
|
|
KR20050045325A
|
|
Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood
|
|
KR20010016261A
|
|
Mixing technique of Umbilical Cord Bloods without immunreaction in case of mixing between mixed Umbilical Cord Blood and Peripheral Blood
|
